Social•Mar 16, 2026
Psychedelic Medicine Shifts From Stigma to Scientific Momentum
1/6 Excited to join @START_Global this week in Switzerland for a fireside chat on the psychedelic medicine opportunity. As co-founder and former CEO of one of the first psychedelics-focused biotechs, I’ve had a front-row seat to this field’s move from stigma to serious science, credible companies, and real clinical momentum. $ATAI $CMPS $GHRS $DFTX
By Florian Brand